AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 108 filers reported holding AVROBIO INC in Q4 2020. The put-call ratio across all filers is 2.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $13,000 | -81.9% | 1,120 | -76.8% | 0.00% | – |
Q4 2020 | $72,000 | +242.9% | 4,834 | +233.6% | 0.00% | – |
Q3 2020 | $21,000 | -51.2% | 1,449 | -41.4% | 0.00% | – |
Q2 2020 | $43,000 | -17.3% | 2,473 | -5.0% | 0.00% | – |
Q4 2019 | $52,000 | +100.0% | 2,604 | +44.0% | 0.00% | – |
Q3 2019 | $26,000 | +23.8% | 1,808 | +37.1% | 0.00% | – |
Q2 2019 | $21,000 | +2000.0% | 1,319 | +1382.0% | 0.00% | – |
Q4 2018 | $1,000 | -50.0% | 89 | +111.9% | 0.00% | – |
Q3 2018 | $2,000 | – | 42 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |